Politicsscore 1078·9 metrosupdated 9m ago

Trump's Pharmaceutical Investments Surge Amid Medicare Exemptions Controversy

A report reveals that President Trump's investments in pharmaceutical companies have skyrocketed, particularly in firms benefiting from Medicare exemptions. This raises ethical concerns as the policy could lead to higher drug costs for Medicare beneficiaries.

Where it's breaking

Local coverage

Sources cited

Original outlets that filed on this story across the contributing metros. Click through for the underlying coverage.

What this is

A national rollup is a story Executive Producer detected breaking in multiple US metros at once. Each contributing market has its own deduplicated cluster from local broadcast, print, government, and community sources — this page links them together so a journalist can see the full national footprint. We are a pointer, not a publisher.Every linked headline goes back to the local cluster and from there to the original outlet — that's the URL to cite. A lead, not the law.